收藏切换
Data mining for adverse events signal of linezolid based on FAERS database
收藏切换
Qingming MO1, 2, Riting ZHU1, Cuifang HAN3, *
World Clinical Drug | 2024, 45(5) : 506 - 513
Less
收藏切换
World Clinical Drug | 2024, 45(5): 506-513
• Article •
Data mining for adverse events signal of linezolid based on FAERS database
Full
Qingming MO1, 2, Riting ZHU1, Cuifang HAN3, *
Affiliations
  • 1.School of Pharmacy, Guangdong Medical University, Dongguan 523000, Guangdong Province, China
  • 2.Department of Pharmacy, the First People's Hospital of Zhaoqing, Zhaoqing 526000, Guangdong Province, China
  • 3.Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan 523000, Guangdong Province, China
Published: 2024-05-10 doi: 10.13683/j.wph.2024.05.010
Outline
收藏切换
Objective

To understand the occurrence of adverse events of linezolid in the real world and evaluate its medication safety, and mine adverse event signals of linezolid based on the data from the FDA Adverse Event Reporting System (FAERS) database, to provide reference for clinical drug treatment monitoring.

Methods

A total of 23 quarters of linezolid adverse event report data from the first quarter of 2018 to the third quarter of 2023 were screened from the FAERS database. After data cleaning, Medicines and Healthcare Products Regulatory Agency (MHRA) comprehensive method. The correlation of adverse events was measured using ROR values and proportional reporting ratio (PRR).

Results

A total of 26 075 adverse event reports with linezolid as the primary suspected drug were obtained, and 619 adverse event signals were mined. The adverse event signals of linezolid involved systemic diseases and reactions at the administration site, infections and infectious diseases, the blood and lymphatic system diseases, and various examinations. Adverse events with strong signals were found to be minimum inhibitory concentration [ROR 95% confidence interval (CI) lower limit=598.04, PRR=1 904.92], sideroblastic anemia (ROR 95% CI lower limit=515.20, PRR=1 108.32) and mediastinal effusion (ROR 95% CI lower limit=369.74, PRR=1 904.92). At the same time, adverse event signals such as trichoglossia (ROR 95% CI lower limit=97.39, PRR=144.43), choroiditis (ROR 95% CI lower limit=200.02, PRR=306.90) and cavernous transformation of portal vein (ROR 95% CI lower limit=180.90, PRR=507.98) were also identified that were not mentioned in the instructions.

Conclusion

Linezolid needs to be closely monitored for poor treatment efficacy and adverse events/reactions related to the blood system during clinical use. The results of this study also remind medical personnel to pay attention to new adverse event signals with strong signal values during drug treatment monitoring to ensure the safety and effectiveness of clinical medication.

linezolid  /  FAERS database  /  adverse events/reactions  /  adverse reactions monitoring
莫庆明, 朱日婷, 韩翠芳. 基于FAERS数据库的利奈唑胺不良事件信号挖掘. 世界临床药物, 2024 , 45 (5) : 506 -513 . DOI: 10.13683/j.wph.2024.05.010
Qingming MO, Riting ZHU, Cuifang HAN. Data mining for adverse events signal of linezolid based on FAERS database[J]. World Clinical Drug, 2024 , 45 (5) : 506 -513 . DOI: 10.13683/j.wph.2024.05.010
Year 2024 volume 45 Issue 5
13
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.05.010
  • Receive Date:2024-01-09
  • Online Date:2026-11-17
  • Published:2024-05-10
Article Data
Affiliations
History
  • Received:2024-01-09
Funding
Affiliations
    1.School of Pharmacy, Guangdong Medical University, Dongguan 523000, Guangdong Province, China
    2.Department of Pharmacy, the First People's Hospital of Zhaoqing, Zhaoqing 526000, Guangdong Province, China
    3.Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan 523000, Guangdong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.05.010
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT